Skip to main content Accessibility help
×
Home
Hostname: page-component-99c86f546-zzcdp Total loading time: 1.638 Render date: 2021-12-06T12:30:24.448Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

11 - Pharmacology

Published online by Cambridge University Press:  27 January 2017

Alison Fiander
Affiliation:
Cardiff University
Baskaran Thilaganathan
Affiliation:
St George’s University London
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
MRCOG Part One
Your Essential Revision Guide
, pp. 391 - 422
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Chan, M, Wong, ICK, Sutcliffe, AG. Prescription drug use in pregnancy: more evidence of safety is needed. The Obstetrician & Gynaecologist 2012;14:8792.CrossRefGoogle Scholar
Tomson, T, Hiilesmaa, V. Epilepsy in pregnancy. BMJ 2007;335:769773.CrossRefGoogle ScholarPubMed
Adab, N, Kini, U, Vinten, J, Ayres, J, Baker, G, Clayton-Smith, J, Coyle, H et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:15751583.CrossRefGoogle ScholarPubMed
Cardonick, E, Iacobucci, A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004 May;5(5):283–91.CrossRefGoogle ScholarPubMed
Al Khaja, KA, Sequeira, RP, Alkhaja, AK et al. Drug treatment of hypertension in pregnancy: a critical review of adult guideline recommendations. J Hypertens. 2014;32(3):454–63.CrossRefGoogle ScholarPubMed
Hypertension in pregnancy. NICE guideline 2015.
Altman, D, Carroli, G, Duley, L et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002 Jun 1;359(9321):1877–90.Google ScholarPubMed
Pre-term labour and birth. NICE guideline 2015.
Nakhai-Pour, H, Broy, P, Sheehy, O et al. Use of non-aspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ 2011: doi: 10.1503/cmaj.110454.CrossRef
Wegrzyniak, L, Repke, J, Ural, S. Treatment of hyperemesis gravidarum. Rev Obstet Gynecol. 2012; 5(2): 7884.Google ScholarPubMed
Whitehead, M I, Townsend, P T, Pryse-Davies, J, Ryder, TA, King, RJB. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. New Engl J Med 1981;305:1599–605.CrossRefGoogle ScholarPubMed
Lethaby, A, Irvine, G, Cameron, I. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 2008;(4): C D 001016.pub2.CrossRefGoogle Scholar
Farquhar, C, Brown, J. Oral contraceptive pills for heavy menstrual bleeding. Cochrane Database Syst Rev 2009;(3):C D 000154.pub2.CrossRefGoogle Scholar
Lethaby, A E, Cooke, I, Rees, M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 2005;(2):C D 002126.pub2.CrossRefGoogle Scholar
Beaumont, H, Augood, C, Duckitt, K, Lethaby, A. Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev 2007;(2):C D 001017.pub2.CrossRefGoogle Scholar
Wong, C L, Farquhar, C, Roberts, H, Proctor, M. Oral contraceptive pill for primary dysmenorrhoea. Cochrane Database Syst Rev 2009(4):C D 002120.pub3.Google Scholar
Davis, L, Kennedy, S S, Moore, J, Prentice, A. Oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 2007;(3):C D 001019.pub2.CrossRefGoogle Scholar
Schweppe, K W. Drug treatment of endometriosis. Contemporary Clinical Gynecology and Obstetrics 2001;2:167–77.Google Scholar
Farmer, J E, Prentice, A, Breeze, A, et al. Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density. Cochrane Database Syst Rev 2003;(4):C D 001297.CrossRefGoogle Scholar
Beral, V, Banks, E, Reeves, G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet 2002;360:942–4.CrossRefGoogle ScholarPubMed
Beral, V, Banks, E, Reeves, G, Appleby, P. Use of H R T and the subsequent risk of cancer. J Epidemiol Biostat 1999;4:191210.Google Scholar
Furness, S, Roberts, H, Majoribanks, J, Lethaby, A. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia. Cochrane Database Syst Rev 2012;(2):C D 000402.pub4.CrossRefGoogle Scholar
Brinton, L A, Hoover, R N. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group. Obstet Gynecol 1993;81:265–71.Google ScholarPubMed
Grady, D, Gebretsadik, T, Kerlikowske, K, Ernster, V, Petitti, D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995;85:304–13.CrossRefGoogle ScholarPubMed
The Writing Group for the P E P I Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (P E P I) Trial. J A M A 1996;275:370–5.
Beresford, S A, Weiss, N S, Voigt, L F, McKnight, B. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet 1997;349:458–61.CrossRefGoogle ScholarPubMed
Rossouw, J E, Anderson, G L, Prentice, R L, LaCroix, A Z, Kooperberg, C, Stefanick, M L, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J A M A 2002;288:321–33.Google ScholarPubMed
Daly, E, Vessey, M P, Hawkins, M M, Carson, J L, Gough, P, Marsh, S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;348:977–80.Google ScholarPubMed
Colditz, G A, Hankinson, S E, Hunter, D J, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl J Med 1995;332:1589–93.CrossRefGoogle Scholar
Anderson, G L, Limacher, M, Assaf, A R, Bassford, T, Beresford, S A, Black, H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. J A M A 2004;291:1701–12.Google ScholarPubMed
Rymer, J, Chapman, M G, Fogelman, I. Effect of tibolone on postmenopausal bone loss. Osteoporosis Int 1994;4:314–17.CrossRefGoogle ScholarPubMed

Send book to Kindle

To send this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Send book to Dropbox

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Dropbox.

Available formats
×

Send book to Google Drive

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Google Drive.

Available formats
×